rss
Arch Dis Child Fetal Neonatal Ed 2008;93:F85-F89 doi:10.1136/adc.2007.119958
  • Original article

Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection

  1. X Carbonell-Estrany1,
  2. J Figueras-Aloy1,
  3. S Salcedo-Abizanda2,
  4. M de la Rosa-Fraile3,
  5. Castrillo Study Group
  1. 1
    Service of Neonatology, Hospital Clínic, Agrupació Sanitèria Clínic, Hospital de Sant Joan de Déu, Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Spain
  2. 2
    Service of Neonatology, Hospital Maternoinfantil Vall d’Hebron, Universitat Autònoma de Barcelona, Spain
  3. 3
    Service of Microbiology, Hospital Virgen de las Nieves, Granada, Spain
  1. Dr X Carbonell-Estrany, Service of Neonatology, Hospital Clínic, C/Sabino Arana 1, E-08028 Barcelona, Spain; xcarbo{at}clinic.ub.es
  • Accepted 9 August 2007
  • Published Online First 17 August 2007

Abstract

Background: The estimated incidence of true early-onset group B streptococcal (GBS) neonatal infection is based on positive GBS blood or cerebrospinal fluid (CSF) culture results, but the real burden of disease is underestimated owing to the high incidence of culture-negative sepsis possibly because of antibiotic administration to the mother.

Objective: To examine the rate of probable early-onset GBS neonatal sepsis and to assess its impact on total GBS neonatal disease.

Design: A multicentre longitudinal prospective surveillance of 107 021 deliveries.

Results: The rates of culture-proven and probable early-onset GBS sepsis were 0.39 and 0.47 per 1000 live births, respectively. Of great concern was the finding of three deaths related to the infection in the group with probable early-onset GBS sepsis.

Conclusions: The use of chemoprophylaxis in GBS-colonised pregnant women, especially when it is incomplete, may not be sufficient to prevent clinical neonatal infection, but may inhibit the growth of GBS in blood and CSF cultures. In assessing the effectiveness of GBS prophylaxis, it is advisable to consider the incidence of culture-positive and probable culture-negative GBS neonatal infection.

Footnotes

  • Competing interests: None.

  • Ethics approval: As the study design was a prospective observational study with no intervention, no ethics committee approval was needed according to the rules of our institutions and country.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. adc.2007.119958v1
    2. 93/2/F85 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.